Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits

References

• Berstad AE, Brabrand K, Foss A. (2009). Clinical utility of microbubble contrast-enhanced ultrasound in the diagnosis of hepatic artery occlusion after liver transplantation. Transplant International 22:954–60
   PubMed Web of Science ®Google Scholar
• Bloemen PGM, Henricks PAJ, Van Bloois L, et al. (1995). Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett 357:140–4
   PubMed Web of Science ®Google Scholar
• Blomley MJ, Cooke JC, Unger EC, et al. (2001). Science, medicine, and the future: Microbubble contrast agents: a new era in ultrasound. BMJ 322:1222
   PubMed Web of Science ®Google Scholar
• Bouffet E, Tabori U, Huang A, Bartels U. (2010). Possibilities of new therapeutic strategies in brain tumors. Cancer Treat Rev 36:335–41
   PubMed Web of Science ®Google Scholar
• Burke CW, Hsiang YHJ, Alexander E, et al. (2011a). Covalently linking poly (lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle. Small 7:1227–35
   PubMed Web of Science ®Google Scholar
• Burke CW, Klibanov AL, Sheehan JP, et al. (2011b). Inhibition of glioma growth by microbubble activation in a subcutaneous model using low duty cycle ultrasound without significant heating: laboratory investigation. J Neurosurg 114:1654–61
   PubMed Web of Science ®Google Scholar
• Chen YS, Alany RG, Young SA, et al. (2011). In vitro release characteristics and cellular uptake of poly (D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. Drug Deliv 18:493–501
   PubMed Web of Science ®Google Scholar
• Domenici F, Giliberti C, Bedini A, et al. (2013). Ultrasound well below the intensity threshold of cavitation can promote efficient uptake of small drug model molecules in fibroblast cells. Drug Deliv 20:285–95
   PubMed Web of Science ®Google Scholar
• Eisenbrey JR, Burstein OM, Kambhampati R, et al. (2010). Development and optimization of a doxorubicin loaded poly (lactic acid) contrast agent for ultrasound directed drug delivery. J Control Release 143:38–44
   PubMed Web of Science ®Google Scholar
• Ferrara K, Pollard R, Borden M. (2007). Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9:415–47
   PubMed Web of Science ®Google Scholar
• Frausher F, Halpern EJ, Horninger W, Bartsch G. (2001). Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet 357:1849–50
   PubMed Web of Science ®Google Scholar
• Gao Z, Kennedy AM, Christensen DA, Rapoport NY. (2008). Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 48:260–70
   PubMed Web of Science ®Google Scholar
• Grayson ACR, Cima MJ, Langer R. (2005). Size and temperature effects on poly (lactic-co-glycolic acid) degradation and microreservoir device performance. Biomaterials 26:2137–45
   PubMed Web of Science ®Google Scholar
• Hernot S, Klibanov AL. (2008). Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60:1153–66
   PubMed Web of Science ®Google Scholar
• Ibsen S, Benchimol M, Simberg D, et al. (2011). A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J Control Release 155:358–66
   PubMed Web of Science ®Google Scholar
• Iyer AK, Khaled G, Fang J, Maeda H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11:812–18
   PubMed Web of Science ®Google Scholar
• Kheirolomoom A, Lai C Y, Tam S M, et al. (2013). Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia. J Control Release 172:266–73
   PubMed Web of Science ®Google Scholar
• Lentacker I, Geers B, Demeester J, et al. (2009). Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 18:101–8
   PubMed Web of Science ®Google Scholar
• Lin R, Ng SL, Wang CH. (2005). In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 26:4476–85
   PubMed Web of Science ®Google Scholar
• Lindner JR. Microbubbles in medical imaging: current applications and future directions. (2004). Nat Rev Drug Discov 3:527–33
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3:1377–97
   PubMed Web of Science ®Google Scholar
• Mayer CR, Geis NA, Katus HA, Bekeredjian R. (2008). Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 5:1121–38
   PubMed Web of Science ®Google Scholar
• Patil RR, Guhagarkar SA, Devarajan PV. (2008). Engineered nanocarriers of doxorubicin: a current update. Crit Rev Ther Drug Carrier Syst 25:1–61
   PubMed Web of Science ®Google Scholar
• Rapoport N. (2004). Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm 277:155–62
   PubMed Web of Science ®Google Scholar
• Rapoport NY, Gao Z, Kamaev P, Christensen DA. (2006). Ultrasound-enhanced localized chemotherapy of drug-sensitive and multidrug resistant tumors [C]//Therapeutic Ultrasound: 5th International Symposium on Therapeutic Ultrasound. 829:481–5
   Google Scholar
• Tartis M S, McCallan J, Lum A F H, et al. (2006). Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 32:1771–80
   PubMed Web of Science ®Google Scholar
• Ting CY, Fan CH, Liu HL, et al. (2012). Concurrent blood–brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 33:704–12
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5
   PubMed Web of Science ®Google Scholar
• Tsutsui JM, Xie F, Porter RT. (2004). The use of microbubbles to target drug delivery. Cardiovasc Ultrasound 2:23–7
   PubMedGoogle Scholar
• Unger EC, McCreery TP, Sweitzer RH, et al. (1998). Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33:886–92
   PubMed Web of Science ®Google Scholar
• Yang R, Chen T, Chen H, et al. (2005). Microfabrication of biodegradable (PLGA) honeycomb-structures and potential applications in implantable drug delivery. Sensors Actuators B 106:506–11
   Web of Science ®Google Scholar